Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan approves Biomerica's 10-minute PSA (prostate specific antigen) test:

This article was originally published in Clinica

Executive Summary

The Japanese Ministry of Health has approved for sale Biomerica's 10-minute, disposable prostate specific antigen (PSA) test for prostate cancer screening. The EZ-PSA is an easy-to-use, one-step, finger-prick-based blood test for use in a doctor's office. It indicates whether a patient has an elevated level of PSA, which can provide an early marker for the disease. "We are very optimistic about this market because the incidence of prostate cancer in Japan has been on the rise over the past 10 years" says Francis Capitanio, president of the Newport Beach, California, company.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT070354

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel